Related Experiment Video
Updated: Feb 22, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
DNA Methylation Mediated Downregulation of miR-449c Controls Osteosarcoma Cell Cycle Progression by Directly
Qing Li1, Hua Li1, Xueling Zhao1
1Department of Orthopedics, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, China.
Abstract:
MicroRNAs (miRNAs) are critical regulators of gene expression, and they have broad roles in the pathogenesis of different diseases including cancer. Limited studies and expression profiles of miRNAs are available in human osteosarcoma cells. By applying a miRNA microarray analysis, we observed a number of miRNAs with abnormal expression in cancerous tissues from osteosarcoma patients. Of particular interest in this study was miR-449c, which was significantly downregulated in osteosarcoma cells and patients, and its expression was negatively correlated with tumor size and tumor MSTS stages. Ectopic expression of miR-449c significantly inhibited osteosarcoma cell proliferation and colony formation ability, and caused cell cycle arrest at the G1 phase. Further analysis identified that miR-449c was able to directly target the oncogene c-Myc and negatively regulated its expression. Overexpression of c-Myc partially reversed miR-449c-mimic-inhibited cell proliferation and colony formation. Moreover, DNA hypermethylation was observed in two CpG islands adjacent to the genomic locus of miR-449c in osteosarcoma cells. Conversely, treatment with the DNA methylation inhibitor AZA caused induction of miR-449c. In conclusion, our results support a model that DNA methylation mediates downregulation of miR-449c, diminishing miR-449c mediated inhibition of c-Myc and thus leading to the activation of downstream targets, eventually contributing to osteosarcoma tumorigenesis.
Insights
MicroRNA-449c (miR-449c) is downregulated in osteosarcoma, inhibiting cancer cell growth by targeting the oncogene c-Myc. DNA hypermethylation contributes to this downregulation, promoting osteosarcoma development.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are key gene regulators involved in various diseases, including cancer.
- Limited miRNA expression data exists for human osteosarcoma.
Purpose of the Study:
- Investigate miRNA expression profiles in osteosarcoma.
- Determine the role of miR-449c in osteosarcoma pathogenesis and its potential therapeutic implications.
Main Methods:
- MicroRNA microarray analysis of osteosarcoma tissues.
- Cell proliferation, colony formation, and cell cycle assays.
- Target gene identification (c-Myc) and methylation analysis.
Main Results:
- miR-449c was significantly downregulated in osteosarcoma, correlating with tumor size and stage.
- miR-449c overexpression inhibited cell proliferation, colony formation, and induced G1 cell cycle arrest.
- miR-449c directly targeted and downregulated the oncogene c-Myc.
- DNA hypermethylation of miR-449c locus and induction by AZA confirmed epigenetic regulation.
Conclusions:
- Downregulation of miR-449c, mediated by DNA hypermethylation, contributes to osteosarcoma tumorigenesis by activating c-Myc.
- miR-449c functions as a tumor suppressor in osteosarcoma.
- Epigenetic silencing of miR-449c presents a potential therapeutic target.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
MicroRNAs
MicroRNAs
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...

